BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shibli F, Kitayama Y, Fass R. Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors. Curr Gastroenterol Rep 2020;22. [DOI: 10.1007/s11894-020-0753-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiao YL, Zhou LY, Hou XH, Li YQ, Zou DW, Chen MH; Chinese Society of Gastroenterology. Chinese expert consensus on gastroesophageal reflux disease in 2020. J Dig Dis 2021;22:376-89. [PMID: 34105263 DOI: 10.1111/1751-2980.13028] [Reference Citation Analysis]
2 Poly TN, Lin M, Syed-abdul S, Huang C, Yang H, Li Y(. Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal. Cancers 2022;14:3052. [DOI: 10.3390/cancers14133052] [Reference Citation Analysis]
3 Spósito L, Fortunato GC, de Camargo BAF, Ramos MADS, Souza MPC, Meneguin AB, Bauab TM, Chorilli M. Exploiting drug delivery systems for oral route in the peptic ulcer disease treatment. J Drug Target 2021;:1-19. [PMID: 33729081 DOI: 10.1080/1061186X.2021.1904249] [Reference Citation Analysis]
4 Lazebnik LB, Golovanova EV, Volel BA, Korochanskaya NV, Lyalyukova EA, Mokshina MV, Mekhtiev SN, Mekhtieva OA, Metsaeva ZV, Petelin DS, Simanenkov VI, Sitkin SI, Cheremushkin SV, Chernogorova MV, Khavkin АI. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. jour 2021. [DOI: 10.31146/1682-8658-ecg-192-8-5-117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Niu CY, Luo XC. Application of potassium competitive acid blockers in acid-related diseases. Shijie Huaren Xiaohua Zazhi 2021; 29(8): 383-388 [DOI: 10.11569/wcjd.v29.i8.383] [Reference Citation Analysis]
6 Leowattana W, Leowattana T. Potassium-competitive acid blockers and gastroesophageal reflux disease. World J Gastroenterol 2022; 28(28): 3608-3619 [DOI: 10.3748/wjg.v28.i28.3608] [Reference Citation Analysis]
7 Domingues G, Moraes-Filho JPP. GASTROESOPHAGEAL REFLUX DISEASE: A PRACTICAL APPROACH. Arq Gastroenterol 2021;58:525-33. [PMID: 34909861 DOI: 10.1590/S0004-2803.202100000-94] [Reference Citation Analysis]
8 Kurin M, Shibli F, Kitayama Y, Kim Y, Fass R. Sorting out the Relationship between Gastroesophageal Reflux Disease and Sleep. Curr Gastroenterol Rep 2021;23:15. [PMID: 34338891 DOI: 10.1007/s11894-021-00815-4] [Reference Citation Analysis]
9 Chapelle N, Ben Ghezala I, Barkun A, Bardou M. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD). Expert Opin Pharmacother 2021;22:219-27. [PMID: 32893683 DOI: 10.1080/14656566.2020.1817385] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]